Subpart I—Payment for Drugs
Sections
Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.
-
447.500
§ 447.500 Basis and purpose. -
447.502
§ 447.502 Definitions. -
447.504
§ 447.504 Determination of average manufacturer price. -
447.505
§ 447.505 Determination of best price. -
447.506
§ 447.506 Authorized generic drugs. -
447.507
§ 447.507 Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs). -
447.508
§ 447.508 Exclusion from best price of certain sales at a nominal price. -
447.509
§ 447.509 Medicaid drug rebates (MDR). -
447.510
§ 447.510 Requirement and penalties for manufacturers. -
447.511
§ 447.511 Requirements for States. -
447.512
§ 447.512 Drugs: Aggregate upper limits of payment. -
447.514
§ 447.514 Upper limits for multiple source drugs. -
447.516
§ 447.516 Upper limits for drugs furnished as part of services. -
447.518
§ 447.518 State plan requirements, findings, and assurances. -
447.520
§ 447.520 Federal Financial Participation (FFP): Conditions relating to physician-administered drugs. -
447.522
§ 447.522 Optional coverage of investigational drugs and other drugs not subject to rebate.